vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MARKETWISE, INC. (MKTW). Click either name above to swap in a different company.
MARKETWISE, INC. is the larger business by last-quarter revenue ($83.4M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). MARKETWISE, INC. runs the higher net margin — 2.3% vs -70.9%, a 73.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -14.4%). MARKETWISE, INC. produced more free cash flow last quarter ($45.6M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -12.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
MarketWise Inc. is a leading provider of investment research, financial market data, and wealth management education solutions. It serves both retail and institutional investors across North America, Europe, and the Asia-Pacific region, offering actionable market insights, portfolio analysis tools, and specialized multi-asset research.
CTKB vs MKTW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $83.4M |
| Net Profit | $-44.1M | $1.9M |
| Gross Margin | 52.9% | 87.0% |
| Operating Margin | -9.0% | 15.8% |
| Net Margin | -70.9% | 2.3% |
| Revenue YoY | 8.1% | -14.4% |
| Net Profit YoY | -557.1% | -9.8% |
| EPS (diluted) | — | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $83.4M | ||
| Q3 25 | $52.3M | $81.3M | ||
| Q2 25 | $45.6M | $80.0M | ||
| Q1 25 | $41.5M | $83.5M | ||
| Q4 24 | $57.5M | $97.5M | ||
| Q3 24 | $51.5M | $97.2M | ||
| Q2 24 | $46.6M | $105.0M | ||
| Q1 24 | $44.9M | $109.0M |
| Q4 25 | $-44.1M | $1.9M | ||
| Q3 25 | $-5.5M | $1.5M | ||
| Q2 25 | $-5.6M | $1.3M | ||
| Q1 25 | $-11.4M | $890.0K | ||
| Q4 24 | $9.6M | $2.1M | ||
| Q3 24 | $941.0K | $1.7M | ||
| Q2 24 | $-10.4M | $1.5M | ||
| Q1 24 | $-6.2M | $1.7M |
| Q4 25 | 52.9% | 87.0% | ||
| Q3 25 | 52.7% | 87.0% | ||
| Q2 25 | 52.3% | 86.3% | ||
| Q1 25 | 48.6% | 85.7% | ||
| Q4 24 | 58.5% | 88.7% | ||
| Q3 24 | 56.3% | 86.7% | ||
| Q2 24 | 54.6% | 87.3% | ||
| Q1 24 | 51.3% | 87.7% |
| Q4 25 | -9.0% | 15.8% | ||
| Q3 25 | -17.6% | 21.9% | ||
| Q2 25 | -23.3% | 18.5% | ||
| Q1 25 | -36.1% | 20.1% | ||
| Q4 24 | 5.2% | 24.8% | ||
| Q3 24 | -8.2% | 22.5% | ||
| Q2 24 | -18.3% | 20.3% | ||
| Q1 24 | -23.9% | 19.8% |
| Q4 25 | -70.9% | 2.3% | ||
| Q3 25 | -10.5% | 1.9% | ||
| Q2 25 | -12.2% | 1.6% | ||
| Q1 25 | -27.5% | 1.1% | ||
| Q4 24 | 16.8% | 2.2% | ||
| Q3 24 | 1.8% | 1.8% | ||
| Q2 24 | -22.4% | 1.5% | ||
| Q1 24 | -13.8% | 1.5% |
| Q4 25 | — | $0.79 | ||
| Q3 25 | — | $0.58 | ||
| Q2 25 | — | $0.53 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $1.06 | ||
| Q3 24 | — | $0.87 | ||
| Q2 24 | — | $0.80 | ||
| Q1 24 | — | $0.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $70.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-11.7M |
| Total Assets | $461.5M | $218.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $70.1M | ||
| Q3 25 | $93.3M | $50.5M | ||
| Q2 25 | $75.5M | $69.1M | ||
| Q1 25 | $95.3M | $79.2M | ||
| Q4 24 | $98.7M | $97.9M | ||
| Q3 24 | $162.3M | $94.1M | ||
| Q2 24 | $177.9M | $109.3M | ||
| Q1 24 | $168.8M | $131.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $707.0K |
| Q4 25 | $341.7M | $-11.7M | ||
| Q3 25 | $378.6M | $-14.5M | ||
| Q2 25 | $377.6M | $-15.8M | ||
| Q1 25 | $379.6M | $-15.8M | ||
| Q4 24 | $395.7M | $-12.5M | ||
| Q3 24 | $385.5M | $-19.5M | ||
| Q2 24 | $389.1M | $-23.7M | ||
| Q1 24 | $392.6M | $-9.4M |
| Q4 25 | $461.5M | $218.4M | ||
| Q3 25 | $494.9M | $201.7M | ||
| Q2 25 | $493.3M | $211.8M | ||
| Q1 25 | $482.6M | $239.6M | ||
| Q4 24 | $499.5M | $259.5M | ||
| Q3 24 | $491.2M | $278.4M | ||
| Q2 24 | $483.7M | $315.3M | ||
| Q1 24 | $492.1M | $359.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $46.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $45.6M |
| FCF MarginFCF / Revenue | -2.9% | 54.6% |
| Capex IntensityCapex / Revenue | 1.6% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 23.84× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $67.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $46.0M | ||
| Q3 25 | $-3.9M | $2.2M | ||
| Q2 25 | $108.0K | $17.8M | ||
| Q1 25 | $-125.0K | $1.7M | ||
| Q4 24 | $2.0M | $-22.1M | ||
| Q3 24 | $13.2M | $-5.8M | ||
| Q2 24 | $6.2M | $-3.8M | ||
| Q1 24 | $4.0M | $-18.5M |
| Q4 25 | $-1.8M | $45.6M | ||
| Q3 25 | $-4.6M | $2.2M | ||
| Q2 25 | $-1.5M | $17.7M | ||
| Q1 25 | $-974.0K | $1.7M | ||
| Q4 24 | $1.1M | $-22.3M | ||
| Q3 24 | $12.2M | $-5.9M | ||
| Q2 24 | $5.2M | $-3.8M | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | 54.6% | ||
| Q3 25 | -8.7% | 2.7% | ||
| Q2 25 | -3.2% | 22.2% | ||
| Q1 25 | -2.3% | 2.0% | ||
| Q4 24 | 1.9% | -22.9% | ||
| Q3 24 | 23.7% | -6.0% | ||
| Q2 24 | 11.0% | -3.6% | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | 0.5% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
| Q4 25 | — | 23.84× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 13.76× | ||
| Q1 25 | — | 1.95× | ||
| Q4 24 | 0.21× | -10.36× | ||
| Q3 24 | 14.05× | -3.39× | ||
| Q2 24 | — | -2.46× | ||
| Q1 24 | — | -11.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MKTW
Segment breakdown not available.
